Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Meperidine for Post-Cesarean Shivering
NCT03115047Phase 3Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- May 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in postanesthetic shivering (PAS) (2 arms), sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoint: Time to stop level III and IV shivering at 15 minutes. Started May 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on NCT03115047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03115047.